bghmc.doh.gov.phbghmc.doh.gov.ph/wp-content/uploads/2018/08/DRUGS-MEDICINES-LIST.pdf · ISOXSUPRINE...

12

Transcript of bghmc.doh.gov.phbghmc.doh.gov.ph/wp-content/uploads/2018/08/DRUGS-MEDICINES-LIST.pdf · ISOXSUPRINE...

Page 1: bghmc.doh.gov.phbghmc.doh.gov.ph/wp-content/uploads/2018/08/DRUGS-MEDICINES-LIST.pdf · ISOXSUPRINE (as hydrochloride), Ini.: 5 mg/ml, 2 ml- ampul 1M, IV infusion KETOROLAC, 30 mg/ml,
Page 2: bghmc.doh.gov.phbghmc.doh.gov.ph/wp-content/uploads/2018/08/DRUGS-MEDICINES-LIST.pdf · ISOXSUPRINE (as hydrochloride), Ini.: 5 mg/ml, 2 ml- ampul 1M, IV infusion KETOROLAC, 30 mg/ml,
Page 3: bghmc.doh.gov.phbghmc.doh.gov.ph/wp-content/uploads/2018/08/DRUGS-MEDICINES-LIST.pdf · ISOXSUPRINE (as hydrochloride), Ini.: 5 mg/ml, 2 ml- ampul 1M, IV infusion KETOROLAC, 30 mg/ml,
Page 4: bghmc.doh.gov.phbghmc.doh.gov.ph/wp-content/uploads/2018/08/DRUGS-MEDICINES-LIST.pdf · ISOXSUPRINE (as hydrochloride), Ini.: 5 mg/ml, 2 ml- ampul 1M, IV infusion KETOROLAC, 30 mg/ml,
Page 5: bghmc.doh.gov.phbghmc.doh.gov.ph/wp-content/uploads/2018/08/DRUGS-MEDICINES-LIST.pdf · ISOXSUPRINE (as hydrochloride), Ini.: 5 mg/ml, 2 ml- ampul 1M, IV infusion KETOROLAC, 30 mg/ml,
Page 6: bghmc.doh.gov.phbghmc.doh.gov.ph/wp-content/uploads/2018/08/DRUGS-MEDICINES-LIST.pdf · ISOXSUPRINE (as hydrochloride), Ini.: 5 mg/ml, 2 ml- ampul 1M, IV infusion KETOROLAC, 30 mg/ml,
Page 7: bghmc.doh.gov.phbghmc.doh.gov.ph/wp-content/uploads/2018/08/DRUGS-MEDICINES-LIST.pdf · ISOXSUPRINE (as hydrochloride), Ini.: 5 mg/ml, 2 ml- ampul 1M, IV infusion KETOROLAC, 30 mg/ml,
Page 8: bghmc.doh.gov.phbghmc.doh.gov.ph/wp-content/uploads/2018/08/DRUGS-MEDICINES-LIST.pdf · ISOXSUPRINE (as hydrochloride), Ini.: 5 mg/ml, 2 ml- ampul 1M, IV infusion KETOROLAC, 30 mg/ml,
Page 9: bghmc.doh.gov.phbghmc.doh.gov.ph/wp-content/uploads/2018/08/DRUGS-MEDICINES-LIST.pdf · ISOXSUPRINE (as hydrochloride), Ini.: 5 mg/ml, 2 ml- ampul 1M, IV infusion KETOROLAC, 30 mg/ml,
Page 10: bghmc.doh.gov.phbghmc.doh.gov.ph/wp-content/uploads/2018/08/DRUGS-MEDICINES-LIST.pdf · ISOXSUPRINE (as hydrochloride), Ini.: 5 mg/ml, 2 ml- ampul 1M, IV infusion KETOROLAC, 30 mg/ml,
Page 11: bghmc.doh.gov.phbghmc.doh.gov.ph/wp-content/uploads/2018/08/DRUGS-MEDICINES-LIST.pdf · ISOXSUPRINE (as hydrochloride), Ini.: 5 mg/ml, 2 ml- ampul 1M, IV infusion KETOROLAC, 30 mg/ml,
Page 12: bghmc.doh.gov.phbghmc.doh.gov.ph/wp-content/uploads/2018/08/DRUGS-MEDICINES-LIST.pdf · ISOXSUPRINE (as hydrochloride), Ini.: 5 mg/ml, 2 ml- ampul 1M, IV infusion KETOROLAC, 30 mg/ml,

Fluconazole 2 mg/ml solution for infusion (fluconazole) · UKPAR Fluconazole 2 mg/ml Solution for Infusion PL 24780/0003 Fluconazole 2 mg/ml solution for infusion (fluconazole) PL

Fluconazole 2 mg/ml solution for infusion (fluconazole) · UKPAR Fluconazole 2 mg/ml Solution for Infusion PL 24780/0003 Fluconazole 2 mg/ml solution for infusion (fluconazole) PL

Janna Minderhoud CPv9 5.pdf · was dilated with topical homatropin (20 mg/ mL) and phenylephrine (100 mg/mL). Topical anaesthesia with lidocaine (40 mg/mL) was ad-ministered immediately

Janna Minderhoud CPv9 5.pdf · was dilated with topical homatropin (20 mg/ mL) and phenylephrine (100 mg/mL). Topical anaesthesia with lidocaine (40 mg/mL) was ad-ministered immediately

ANIMAL HEALTH PRODUCTS - bavet.com.tr€¦ · 100 mg/ml menbutone 25 mg/ml Polymerized silicone 500.000 IU/ml Vitamin A, 75.000 IU/ml Vitamin D3, 50 mg/ml Vitamin E 100 mg/ml Butaphosphan,

ANIMAL HEALTH PRODUCTS - bavet.com.tr€¦ · 100 mg/ml menbutone 25 mg/ml Polymerized silicone 500.000 IU/ml Vitamin A, 75.000 IU/ml Vitamin D3, 50 mg/ml Vitamin E 100 mg/ml Butaphosphan,

PRODUCT MONOGRAPH...PRODUCT MONOGRAPH Pr CABAZITAXEL FOR INJECTION Manufacturer’s Standard Concentrated Solution 10 mg/mL (45 mg/4.5 mL & 60 mg/6 mL) Antineoplastic Agent L01CD04

PRODUCT MONOGRAPH...PRODUCT MONOGRAPH Pr CABAZITAXEL FOR INJECTION Manufacturer’s Standard Concentrated Solution 10 mg/mL (45 mg/4.5 mL & 60 mg/6 mL) Antineoplastic Agent L01CD04

0.96 mg/ml

0.96 mg/ml

E-ISSN: In-vitro anticancer activity of petroleum ether ... · petroleum ether extracts (0.078 mg/ml, 0.156 mg/ml, 0.312 mg/ml, 0.625, 1.25 mg/ml, 2.5 mg/ml, 5 mg/ml, 10 mg/ml) were

E-ISSN: In-vitro anticancer activity of petroleum ether ... · petroleum ether extracts (0.078 mg/ml, 0.156 mg/ml, 0.312 mg/ml, 0.625, 1.25 mg/ml, 2.5 mg/ml, 5 mg/ml, 10 mg/ml) were

FUROSEMIDE 20 MG/5 ML, 40 MG/5 ML AND 50 MG/5 ML ORAL SOLUTION PL 04917/0072 … · 2015-01-19 · ml Oral Solution (PL 04917/0072-74) ... Lasix 10 mg/ml Liquid ... 330.7 MHRA PAR

FUROSEMIDE 20 MG/5 ML, 40 MG/5 ML AND 50 MG/5 ML ORAL SOLUTION PL 04917/0072 … · 2015-01-19 · ml Oral Solution (PL 04917/0072-74) ... Lasix 10 mg/ml Liquid ... 330.7 MHRA PAR

400 mg/5 ml de amoxicilina tri-hidratada + 57 mg/5 ml de ...

400 mg/5 ml de amoxicilina tri-hidratada + 57 mg/5 ml de ...

FARM ANIMALS PRODUCTS€¦ · 100 mg/ml menbutone 25 mg/ml Polymerized silicone 500.000 IU/ml Vitamin A, 75.000 IU/ml Vitamin D3, 50 mg/ml Vitamin E 100 mg/ml Butaphosphan, 0.05 mg/ml

FARM ANIMALS PRODUCTS€¦ · 100 mg/ml menbutone 25 mg/ml Polymerized silicone 500.000 IU/ml Vitamin A, 75.000 IU/ml Vitamin D3, 50 mg/ml Vitamin E 100 mg/ml Butaphosphan, 0.05 mg/ml

Fentanyl Decontamination Studies€¦ · Decon mass[mL]) Target mass (mg) Decon volume (mL) Sample pH Dilution Volume(mL) Expected Concentration (mg/mL) 2Observed Concentration (mg/mL)

Fentanyl Decontamination Studies€¦ · Decon mass[mL]) Target mass (mg) Decon volume (mL) Sample pH Dilution Volume(mL) Expected Concentration (mg/mL) 2Observed Concentration (mg/mL)

Haldol - Art 30 - Assessment Report · mg/ml and 10 mg/ml) and injectable solution (5 mg/ml). 2. Scientific discussion 2.1. Introduction Haldol, which contains the active substance

Haldol - Art 30 - Assessment Report · mg/ml and 10 mg/ml) and injectable solution (5 mg/ml). 2. Scientific discussion 2.1. Introduction Haldol, which contains the active substance

Site web de la Pharmacie des HUG http :// ... · PDF fileADRENALINE HUG PSE Perfusion IV continue(adrénaline = épinéphrine) ... Amp. 0.25 mg/ 1 mL mg/ 1 mL mg/ 1 mL Solution IM,

Site web de la Pharmacie des HUG http :// ... · PDF fileADRENALINE HUG PSE Perfusion IV continue(adrénaline = épinéphrine) ... Amp. 0.25 mg/ 1 mL mg/ 1 mL mg/ 1 mL Solution IM,

mg mg mg ml mg mg mg mg ml scored tab scored tab tab top cream s.c tab susp steril eye dro syrup tab tab tab tab tab oint. syrup tab top oint tab acarbose ... proluton depot ombtvent

mg mg mg ml mg mg mg mg ml scored tab scored tab tab top cream s.c tab susp steril eye dro syrup tab tab tab tab tab oint. syrup tab top oint tab acarbose ... proluton depot ombtvent

Erbitux 5 mg/mL Erbitux 5 mg/mL

Erbitux 5 mg/mL Erbitux 5 mg/mL

CARBOPLATIN 10 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION ... · MHRA-UKPAR – Carboplatin 10 mg/ml Concentrate for Solution for Infusion PL 08137/0150-2 -1 - CARBOPLATIN 10 MG/ML

CARBOPLATIN 10 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION ... · MHRA-UKPAR – Carboplatin 10 mg/ml Concentrate for Solution for Infusion PL 08137/0150-2 -1 - CARBOPLATIN 10 MG/ML

CHARACTERISTICS OF VARIOFILL BODY CONTOUR · Hyacorp Variofill Concentration 20 mg/ml 20 mg/ml 33mg/ml Syringe 10 ml 10 ml 10 ml Amount to inject to obtain visible effects (total

CHARACTERISTICS OF VARIOFILL BODY CONTOUR · Hyacorp Variofill Concentration 20 mg/ml 20 mg/ml 33mg/ml Syringe 10 ml 10 ml 10 ml Amount to inject to obtain visible effects (total

PHENOXYMETHYLPENICILLIN 125 MG/5 ML AND 250MG/5ML SUGAR ... · MHRA-UKPAR – Phenoxymethylpenicillin 125 mg/5 mL and 250 mg/5 mL Oral Solution Sugar free BP PL 17907/0248-9 -2 -

PHENOXYMETHYLPENICILLIN 125 MG/5 ML AND 250MG/5ML SUGAR ... · MHRA-UKPAR – Phenoxymethylpenicillin 125 mg/5 mL and 250 mg/5 mL Oral Solution Sugar free BP PL 17907/0248-9 -2 -

Vectibix 20 Mg-ml Concentrado_WC500047710

Vectibix 20 Mg-ml Concentrado_WC500047710

DEVELOPMENT OF CELL-BASED ASSAY TO ASSESS THE … · 2020-01-14 · [2] Cells treated with extracts A (0,1 mg/ml et 1 mg/ml), B (0,1 mg/ml) and D (1 mg/ml) showed a significant decrease

DEVELOPMENT OF CELL-BASED ASSAY TO ASSESS THE … · 2020-01-14 · [2] Cells treated with extracts A (0,1 mg/ml et 1 mg/ml), B (0,1 mg/ml) and D (1 mg/ml) showed a significant decrease

UNIVERSITI PUTRA MALAYSIA ANTIMICROBIAL AND WOUND …psasir.upm.edu.my/id/eprint/6530/1/FPSK(M)_2004_7A.pdf · mg/ml), penisilin G (l0 mg/ml), eritromisin (15 mg/ml), tetrasiklin

UNIVERSITI PUTRA MALAYSIA ANTIMICROBIAL AND WOUND …psasir.upm.edu.my/id/eprint/6530/1/FPSK(M)_2004_7A.pdf · mg/ml), penisilin G (l0 mg/ml), eritromisin (15 mg/ml), tetrasiklin